Remove tag therapeutic-compounds
article thumbnail

Oligonucleotide synthesis market to reach $16.7 billion by 2027

European Pharmaceutical Review

billion by 2027 during the forecast period, due to the rise in ongoing clinical trials for oligonucleotide-based therapies in key therapeutic sectors such as oncology. The research projected a compound annual growth rate (CAGR) of 16.8 Tag Copenhagen A/S (Denmark). Sarepta Therapeutics, Inc. (US). percent from $7.7

article thumbnail

Cannabinoids receptors: popular preclinical target but banned in 137 countries

Pharmaceutical Technology

Cannabinoid receptors are a popular therapeutic target for cannabinoid-based drugs in the treatment of pain, neurological disorders and inflammation, according to GlobalData’s Pharma Intelligence Centre Drugs database. Cannabinoid-based drugs are derived from compounds found in the cannabis plant.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Actualising the power of antibody-drug conjugates as cancer therapeutics

European Pharmaceutical Review

ANTIBODY-DRUG conjugates (ADCs) are therapeutic molecules designed as highly targeted medicines with the promise of changing the way we treat cancer and other diseases. A key aspect in removing many existing hurdles lies in the linker and conjugation of the two therapeutic modalities while maintaining the properties of the naked antibody.

article thumbnail

Addressing Cultural Competency: Healthcare for Refugees & Minority Populations

Colors Make me Happy

A simply inability to communicate can further compound cultural barriers, cause stress, and lead to poorer health outcomes for refugees. From my experience, patients may seek urgent care simply because they want to share their trauma with another human and be heard, a form of therapeutic treatment in itself.

article thumbnail

Putting complex medicines under the microscope

European Pharmaceutical Review

Complex medicines offer diverse therapeutic modalities, including RNA therapeutics and antibody-drug conjugates (ADCs). BT-474 cell line was gene-edited to incorporate a green fluorescent protein (GFP) tag into late endosomes/lysosomes (green). Physical characterisation.

article thumbnail

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

I mean, you know, there has obviously been a lot of breakthrough biologics and different therapeutics like around cancers and things like that, that have high price tags because maybe they don’t have as big a market as you know, something’s wrong, you know blood pressure medication.